Orser Capital Management, LLC Abbott Laboratories Transaction History

Orser Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$102.07 - $123.37 $1,837 - $2,220	18 Added 0.55%	3,313 $360,000
Q1 2022 Apr 11, 2022	BUY	$114.02 - $139.04 $68,412 - $83,424	600 Added 22.26%	3,295 $390,000
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $10,884 - $12,822	-100 Reduced 3.58%	2,695 $323,000
Q2 2020 Jul 29, 2020	SELL	$76.57 - $98.0 $14,624 - $18,718	-191 Reduced 6.4%	2,795 $256,000
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $11,998 - $17,545	191 Added 6.83%	2,986 $236,000
Q4 2019 Jan 17, 2020	BUY	$78.51 - $87.4 $133,467 - $148,580	1,700 Added 155.25%	2,795 $243,000
Q3 2019 Oct 31, 2019	BUY	$81.84 - $88.74 $89,614 - $97,170	1,095 New	1,095 $91,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Orser Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Orser Capital Management, LLC with notifications on news.